Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec 19:9:1838.
doi: 10.3389/fphys.2018.01838. eCollection 2018.

Obesity and Preeclampsia: Common Pathophysiological Mechanisms

Affiliations
Review

Obesity and Preeclampsia: Common Pathophysiological Mechanisms

Patricio Lopez-Jaramillo et al. Front Physiol. .

Abstract

Preeclampsia is a disorder specific of the human being that appears after 20 weeks of pregnancy, characterized by new onset of hypertension and proteinuria. Abnormal placentation and reduced placental perfusion associated to impaired trophoblast invasion and alteration in the compliance of uterine spiral arteries are the early pathological findings that are present before the clinical manifestations of preeclampsia. Later on, the endothelial and vascular dysfunction responsible of the characteristic vasoconstriction of preeclampsia appear. Different nutritional risk factors such as a maternal deficit in the intake of calcium, protein, vitamins and essential fatty acids, have been shown to play a role in the genesis of preeclampsia, but also an excess of weight gain during pregnancy or a pre-pregnancy state of obesity and overweight, which are associated to hyperinsulinism, insulin resistance and maternal systemic inflammation, are proposed as one of the mechanism that conduce to endothelial dysfunction, hypertension, proteinuria, thrombotic responses, multi-organ damage, and high maternal mortality and morbidity. Moreover, it has been demonstrated that pregnant women that suffer preeclampsia will have an increased risk of future cardiovascular disease and related mortality in their later life. In this article we will discuss the results of studies performed in different populations that have shown an interrelationship between obesity and overweight with the presence of preeclampsia. Moreover, we will review some of the common mechanisms that explain this interrelationship, particularly the alterations in the L-arginine/nitric oxide pathway as a crucial mechanism that is common to obesity, preeclampsia and cardiovascular diseases.

Keywords: cardiovascular risk; endothelial dysfunction; nitric oxide; obesity; preeclampsia.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Mechanisms linking obesity to preeclampsia. Insulin resistance that results of pre-pregnancy obesity or by an excessive weight gain during gestation is associated with a reduced cytotrophoblast migration and uterine spiral artery remodeling, which in turn conduce to placental hypoxia and ischemia. In this condition the placenta release of soluble anti-angiogenic factors and inflammatory factors into the maternal circulation promoting the endothelial dysfunction, which is characterized by a decrease in the endothelial production of nitric oxide and an increase in the oxidative stress, that results in the characteristic symptoms of preeclampsia: hypertension, proteinuria, and edema.

References

    1. Accini L., Sotomayor A., Trujillo F., Barrera J. G., Bautista L., López-Jaramillo P. (2001). Colombian Study to Assess the Use of Noninvasive Determination of Endothelium-Mediated Vasodilatation (CANDEV). Normal values and factors associated. Endothelium 8 157–166. 10.3109/10623320109165324 - DOI - PubMed
    1. Baksu B., Davas I., Baksu A., Akyol A., Gulbaba G. (2005). Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women. Int. J. Gynaecol. Obstet. 90 112–117. 10.1016/j.ijgo.2005.04.018 - DOI - PubMed
    1. Bellamy L., Casas J. P., Hingorani A. D., Williams D. J. (2007). Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335:974. 10.1136/bmj.39335.385301.BE - DOI - PMC - PubMed
    1. Benyo D. F., Smarason A., Redman C. W., Sims C., Conrad K. P. (2001). Expression of inflammatory cytokines in placentas from women with preeclampsia. J. Clin. Endocrinol. Metab. 86 2505–2512. 10.1210/jcem.86.6.7585 - DOI - PubMed
    1. Bodnar L. M., Catov J. M., Klebanoff M. A., Ness R. B., Roberts J. M. (2007). Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 18 234–239. 10.1097/01.ede.0000254119.99660.e7 - DOI - PubMed